Outcomes & ratings

Who’s on my team?

Based on specialized physician count, Mayo Clinic has one of the largest programs in the nation devoted to lymphoma care. Our multidisciplinary lymphoma care team includes lymphoma clinicians, as well as lymphoma pathologists, radiation oncologists, radiologists and dermatologists who have dedicated their careers to treating lymphoma.

Our teams of advanced practitioners, pharmacists, nurses, research coordinators, desk operations specialists and operations managers work together with unparalleled communication and coordination to deliver world-class care. Team members representing all roles meet regularly to discuss individual patients, continually improving the quality of care delivered at Mayo Clinic.

Our expert physicians treat rare forms of lymphoma and work across specialties as well as with your local health care provider to design the care that is right for you, whether that means treatment at Mayo Clinic or treatment from your local provider. Our program is embedded within an organization that focuses on multidisciplinary team-based care and is home to over 4,000 physicians and scientists, so patients with other conditions in addition to lymphoma receive coordinated care from world-class specialists across many specialties.

Mayo Clinic lymphoma physicians and researchers are internationally recognized leaders in their field and have key leadership roles in numerous national and international health- and lymphoma-related organizations. Our experience as leaders in these organizations enables us to provide world-leading lymphoma care.

Mayo Clinic physicians and researchers have key leadership positions in many national and international health- and lymphoma-related organizations, including:

  • American Society for Transplantation and Cellular Therapy
  • Eastern Cooperative Oncology Group-American College of Radiology Imaging Network
  • International Extranodal Lymphoma Study Group Board of Directors
  • International Lymphoma Epidemiology Consortium
  • International Waldenstrom’s Macroglobulinemia Foundation Scientific Advisory Committee
  • Leukemia & Lymphoma Society Medical & Scientific Affairs Committee
  • Lymphoma Research Foundation
  • National Cancer Institute Lymphoma Steering Committee
  • National Comprehensive Cancer Center Network Guideline Steering Committee

Outcomes & ratings

May 05, 2022
  1. Lymphoma — Hodgkin. Cancer.net. https://www.cancer.net/cancer-types/lymphoma-hodgkin/view-all. Accessed Sept. 1, 2019.
  2. Lymphoma — Non-Hodgkin. Cancer.net. https://www.cancer.net/cancer-types/lymphoma-non-hodgkin/view-all. Accessed Sept. 1, 2019.
  3. Adult Hodgkin lymphoma treatment (PDQ) — Health professional version. National Cancer Institute. https://www.cancer.gov/types/lymphoma/hp/adult-hodgkin-treatment-pdq. Accessed Sept. 1, 2019.
  4. Adult non-Hodgkin lymphoma treatment (PDQ) — Health professional version. National Cancer Institute. https://www.cancer.gov/types/lymphoma/hp/adult-nhl-treatment-pdq. Accessed Sept. 1, 2019.
  5. Warner KJ. Allscripts EPSi. Mayo Clinic. July 2, 2019.
  6. Lymphoma SPOREs. National Cancer Institute. https://trp.cancer.gov/spores/lymphoma.htm. Accessed Sept. 1, 2019.
  7. Hoffman R, et al. Hematology: Basic Principles and Practice. 7th ed. Elsevier; 2018. https://www.clinicalkey.com. Accessed June 13, 2019.
  8. Laurent C, et al. Impact of expert pathologic review of lymphoma diagnosis: Study of patients from the French Lymphopath Network. Journal of Clinical Oncology. 2017; doi: 10.1200/JCO.2016.71.2083.
  9. Mayo Clinic first in the U.S. to offer genetic test for lymphoma. Forefront. 2017;6. https://www.mayo.edu/research/forefront/mayo-clinic-first-us-offer-genetic-test-lymphoma. Accessed Sept. 1, 2019.
  10. Distress management. National Comprehensive Cancer Network. https://www.nccn.org/professionals/physician_gls/default.aspx. Accessed Sept. 1, 2019.